In the last decade, the treatment of non-small cell lung cancer (NSCLC) has been
revolutionized by the introduction of immune checkpoint inhibitors (ICI) directed against …

IL-17 cytokines are expressed by numerous cells (eg, gamma delta (γδ) T, innate lymphoid
(ILC), Th17, epithelial cells). They contribute to the elimination of bacteria through the …

Regulatory T cells (Treg), as members of CD4+ T cells, have garnered extensive attention in
the research of tumor progression. Treg cells have the function of inhibiting the immune …

Increasing evidence suggests that besides mutational and molecular alterations, the
immune component of the tumor microenvironment also substantially impacts tumor …

KRAS mutations are one of the most frequent oncogenic mutations of all human cancers,
being more prevalent in pancreatic, colorectal, and lung cancers. Intensive efforts have been …

Simple Summary Lung cancer is one of the most common and deadly malignancies
worldwide. Microscopic examination of histological and cytological lung specimens can be a …

Lung cancer is the most common cause of cancer-related deaths. Lung cancers can be
classified as small-cell (SCLC) or non-small cell (NSCLC). About 84% of all lung cancers …

Simple Summary The world of small molecules in solid tumors as cancer stem cells (CSCs),
circulating tumor cells (CTCs) and cancer-associated fibroblasts (CAFs) continues to be …

Inflammatory markers have a wide range of predictive values in the prognosis of non-small
lung cancer (NSCLC). Poor nutritional status usually means a poor prognosis in patients …

Objectives We aimed to compare the prognostic value of inflammatory biomarkers extracted
from pretreatment peripheral blood and [18F]-FDG PET for estimating outcomes in non-small …